Shanghai Allist Pharmaceuticals Co. Ltd. Class ASSE: 688578

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of AST2169 Liposome for Injection

· Issued by Shanghai Allist Pharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange

On 6ix: 6ix.com/news/announcement-on-voluntary-disclosure-of-obtaining-notice-of-approval-for-drug-clinical-trial-of-ast2169-liposome-for-injection


Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of AST2169 Liposome for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis